Cargando…
Effect of anti-obesity agent HSG4112 on overweight and obese patients following 12 weeks of oral treatment: a study protocol for a randomised, double-blind, placebo-controlled, parallel-group, phase 2a clinical trial
Background: Glaceum Inc. has proposed HSG4112, a structural analogue of glabridin, as a novel anti-obesity compound. Animal studies and phase I human trials have shown that HSG4112 improves energy consumption, normalises weight, and is safe and drug-resistant. Based on these results, the company pla...
Autores principales: | Min, Kyungha, Oh, Bumjo, Koo, Hye Yeon, Kim, Yang-Hyun, Lee, Ji-Won, Lee, Sangsub, Kim, Youngah, Kwon, Hyuktae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483829/ https://www.ncbi.nlm.nih.gov/pubmed/37693914 http://dx.doi.org/10.3389/fphar.2023.1177539 |
Ejemplares similares
-
Species Differences in Stereoselective Pharmacokinetics of HSG4112, A New Anti-Obesity Agent
por: Bae, In Yong, et al.
Publicado: (2020) -
Discovery and preclinical efficacy of HSG4112, a synthetic structural analog of glabridin, for the treatment of obesity
por: Choi, Leo Sungwong, et al.
Publicado: (2020) -
Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trial
por: Baek, Hyang-Im, et al.
Publicado: (2023) -
Hysterosalpingographic (HSG) Pattern of Infertility in Women of Reproductive Age
por: Onwuchekwa, Chinwe R., et al.
Publicado: (2017) -
Onion peel extract reduces the percentage of body fat in overweight and obese subjects: a 12-week, randomized, double-blind, placebo-controlled study
por: Lee, Ji-Sook, et al.
Publicado: (2016)